The Motley Fool

Key Data Points

Primary metrics and data points about Theravance, Inc..
Current Price: $8.75
Prev Close: $8.71
Open: $8.62
Bid: $6.10
Ask: $9.60
Day's Range: $8.37 - $8.84
52wk Range: $6.36 - $21.16
Volume: 1,065,184
Avg Vol 1,328,216
Market Cap: $1B
P/E (ttm): -17.78
EPS (ttm): ($0.49)
Div & Yield: $1.00 (11.5%)

Business Summary

Industry, sector and description for Theravance, Inc..

A biopharmaceutical company focuses on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and gastrointestinal motility dysfunction.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

THRX vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Theravance, Inc..
CAPS Rating 3 out of 5
95 Outperform
30 Underperform
CAPS All Stars
33 Outperform
7 Underperform

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Rick E. Winningham, CEO

100% Approve

Based on 4 Ratings

More Details for TheravanceJobs

Powered by

More Details about Theravance, Inc.

Primary metrics and data points about Theravance, Inc..